FAM110C | Family with sequence similarity 110, member C | | | | | | Mixed |
ACP1 | Acid phosphatase 1, soluble | Enzymes Plasma proteins
| | | | | Expressed in all |
TPO | Thyroid peroxidase | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
TSSC1 | Tumor suppressing subtransferable candidate 1 | | | | | | Expressed in all |
ADI1 | Acireductone dioxygenase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
RPS7 | Ribosomal protein S7 | Disease related genes Ribosomal proteins
| | | | | Expressed in all |
ALLC | Allantoicase | Enzymes
| | | | | Tissue enriched |
CMPK2 | Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Mixed |
ID2 | Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | Cancer-related genes Transcription factors
| | | | | Expressed in all |
KIDINS220 | Kinase D-interacting substrate, 220kDa | Predicted membrane proteins
| | | | | Expressed in all |
ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | | | | | | Mixed |
IAH1 | Isoamyl acetate-hydrolyzing esterase 1 homolog (S. cerevisiae) | | | | | | Expressed in all |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GRHL1 | Grainyhead-like 1 (Drosophila) | Transcription factors
| | | | | Tissue enhanced |
RRM2 | Ribonucleotide reductase M2 | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NOL10 | Nucleolar protein 10 | | | | | | Expressed in all |
PDIA6 | Protein disulfide isomerase family A, member 6 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
C2orf50 | Chromosome 2 open reading frame 50 | | | | | | Tissue enriched |
ROCK2 | Rho-associated, coiled-coil containing protein kinase 2 | Enzymes Plasma proteins
| | | | | Expressed in all |
NBAS | Neuroblastoma amplified sequence | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
DDX1 | DEAD (Asp-Glu-Ala-Asp) box helicase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
SMC6 | Structural maintenance of chromosomes 6 | | | | | | Expressed in all |
RDH14 | Retinol dehydrogenase 14 (all-trans/9-cis/11-cis) | | | | | | Expressed in all |
LAPTM4A | Lysosomal protein transmembrane 4 alpha | Predicted membrane proteins
| | | | | Expressed in all |
SDC1 | Syndecan 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
PUM2 | Pumilio RNA-binding family member 2 | | | | | | Expressed in all |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ATAD2B | ATPase family, AAA domain containing 2B | Plasma proteins
| | | | | Expressed in all |
MFSD2B | Major facilitator superfamily domain containing 2B | Predicted membrane proteins
| | | | | Tissue enriched |
SF3B14 | Pre-mRNA branch site protein p14 | Plasma proteins
| | | | | Expressed in all |
TP53I3 | Tumor protein p53 inducible protein 3 | | | | | | Expressed in all |
ITSN2 | Intersectin 2 | | | | | | Expressed in all |
NCOA1 | Nuclear receptor coactivator 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
CENPO | Centromere protein O | | | | | | Mixed |
ADCY3 | Adenylate cyclase 3 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DNAJC27 | DnaJ (Hsp40) homolog, subfamily C, member 27 | | | | | | Expressed in all |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
DTNB | Dystrobrevin, beta | Plasma proteins
| | | | | Expressed in all |
ASXL2 | Additional sex combs like 2 (Drosophila) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
HADHA | Hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
HADHB | Hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
GPR113 | G protein-coupled receptor 113 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CENPA | Centromere protein A | | | | | | Mixed |
DPYSL5 | Dihydropyrimidinase-like 5 | Plasma proteins
| | | | | Group enriched |
MAPRE3 | Microtubule-associated protein, RP/EB family, member 3 | | | | | | Expressed in all |
TMEM214 | Transmembrane protein 214 | Predicted membrane proteins
| | | | | Expressed in all |
EMILIN1 | Elastin microfibril interfacer 1 | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
PREB | Prolactin regulatory element binding | Predicted membrane proteins
| | | | | Expressed in all |